ANTIBIOTIC RESISTANCE OF <i>S.PNEUMONIAE</i> STRAINS CIRCULATING IN ALMATY AGAINST THE BACKGROUND OF UNIVERSAL IMMUNIZATION
According to the World Health Organization (WHO), pneumococcal infection is one of the most dangerous and common infections prevented by vaccination. Resistance of pneumococcus to antibacterial drugs is a global problem that complicates the fight against infection throughout the world. Since it complicates the treatment of patients with various forms of pneumococcal diseases, it requires the use of more and more new antimicrobial drugs; increases the duration of hospitalization and, accordingly, the cost of treatment. In this regard, at present, vaccination is recognized as the leading direction in preventing the development of infections caused by antibiotic-resistant pneumococci [1]. In this regard, emphasis should be placed on the study of approaches to antibacterial therapy of pneumococcal infections based on the isolation of S.pneumoniae strains in children.